Skip to content

Drug interactions

Ethinyl estradiol-drospirenone + Rasagiline

Severity: Minor

Ethinyl estradiol-drospirenone and Rasagiline: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rasagiline is cleared mainly by CYP1A2, and ethinyl estradiol inhibits this enzyme weakly. Rasagiline exposure may rise, increasing its adverse effects.

What this interaction means in plain words

Ethinyl estradiol-drospirenone and Rasagiline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ethinyl estradiol-drospirenone belongs to Endocrine; Rasagiline belongs to Central Nervous System.

Evidence level: Low

Why it happens

Weak CYP1A2 inhibition by ethinyl estradiol reducing rasagiline clearance.

What to do

Monitor for increased rasagiline effects such as dizziness, hypotension and dyskinesia, and keep the dose at 0.5 mg daily if CYP1A2 inhibition is clinically relevant.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ethinyl estradiol-drospirenone and Rasagiline, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ethinyl estradiol-drospirenone with Rasagiline?

MediHelp rates the interaction as minor. Ethinyl estradiol-drospirenone and Rasagiline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Rasagiline is cleared mainly by CYP1A2, and ethinyl estradiol inhibits this enzyme weakly. Rasagiline exposure may rise, increasing its adverse effects.

How serious is the interaction between Ethinyl estradiol-drospirenone and Rasagiline?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for increased rasagiline effects such as dizziness, hypotension and dyskinesia, and keep the dose at 0.5 mg daily if CYP1A2 inhibition is clinically relevant.

What other medicines interact with Ethinyl estradiol-drospirenone?

MediHelp also lists interactions of Ethinyl estradiol-drospirenone with, for example, Fezolinetant, Ombitasvir / paritaprevir / ritonavir, Ombitasvir / paritaprevir / ritonavir and dasabuvir. The full list is on the Ethinyl estradiol-drospirenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in